Global ART Outcomes Continue to Improve
Rada Medical

Global ART Outcomes Continue to Improve

The latest ICMART World Report, published in Human Reproduction (2025), provides one of the most comprehensive analyses of assisted reproductive technology (ART) worldwide, covering data from 83 countries and more than 3.5 million treatment cycles.

 

Key findings include:

- More than 865,000 babies were born through ART during the reporting period.

- Continued adoption of single embryo transfer (SET) has been accompanied by a sustained decline in multiple pregnancies, improving treatment safety.

- The use of frozen embryo transfer (FET) and preimplantation genetic testing (PGT) continues to increase as laboratories adopt more advanced clinical protocols.

- Live birth outcomes remain strong across modern ART programs, reflecting ongoing advances in embryology, laboratory technologies, cryopreservation, and evidence-based clinical practice.

Together, these global data demonstrate the continued evolution of reproductive medicine, where technological innovation, standardized laboratory practice, and clinical expertise are translating into better patient outcomes worldwide.

At RADA, we develop IVF consumables that support precision, consistency, and reliable performance throughout every stage of assisted reproduction.

 

Quality First. Results Always.

 

Sharing in:
Rada Medical

Rada Medical

RADA, a brand owned by Behrad Rooyesh Royan Company, is a medical device manufacturer dedicated to supporting individuals and families on their journey to parenthood and advancing women’s health. Through safe and effective solutions for assisted reproduction and gynecological care, rada empowers healthcare professionals to deliver reliable and high-quality patient care.

Copyright © 2026 Behrad Royesh Royan Co. (RADA brand) All rights reserved.
Development & Design | Donyadideh Company